Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-11-01

FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from Sandoz Inc. This action approves a supplement to the original NDA, potentia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamterene and Hydrochlorothiazide (Triamterene and hydrochlorothiazide)

Snippet

SUPPL AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)